ED
K

Exane Derivatives’s Kellanova K Stock Holding History

Exane Derivatives’s Portfolio K Stock Details K Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.03M Sell
15,356
-2,160
-12% -$140K 0.59% 40
2022
Q1 		$1.06M Buy
17,516
+2,999
+21% +$180K 0.3% 84
2021
Q4 		$878K Buy
14,517
+873
+6% +$51.5K 0.21% 104
2021
Q3 		$819K Buy
13,644
+3,208
+31% +$192K 0.2% 111
2021
Q2 		$619K Buy
10,436
+424
+4% +$25.8K 0.14% 144
2021
Q1 		$595K Buy
10,012
+9,935
+12,903% +$556K 0.17% 130
2020
Q4 		$4.48K Hold
77
– – ﹤0.01% 567
2020
Q3 		$4.65K Hold
77
– – ﹤0.01% 509
2020
Q2 		$4.76K Sell
77
-448
-85% -$27.1K ﹤0.01% 455
2020
Q1 		$29.6K Hold
525
– – 0.01% 390
2019
Q4 		$34.6K Sell
525
-3,475
-87% -$211K 0.01% 371
2019
Q3 		$242K Hold
4,000
– – 0.04% 220
2019
Q2 		$201K Buy
4,000
+490
+14% +$26K 0.04% 266
2019
Q1 		$189K Buy
3,510
+594
+20% +$31.7K 0.04% 223
2018
Q4 		$156K Buy
2,916
+1,959
+205% +$118K 0.03% 277
2018
Q3 		$62.9K Sell
957
-1,110
-54% -$74.8K 0.01% 360
2018
Q2 		$135K Sell
2,067
-2,569
-55% -$153K 0.02% 301
2018
Q1 		$281K Buy
4,636
+3,449
+291% +$218K 0.06% 217
2017
Q4 		$75.8K Sell
1,187
-758
-39% -$45.6K 0.01% 311
2017
Q3 		$114K Sell
1,945
-505
-21% -$31.9K 0.02% 241
2017
Q2 		$160K Buy
2,450
+478
+24% +$32.1K 0.03% 217
2017
Q1 		$134K Buy
1,972
+1,494
+313% +$103K 0.03% 211
2016
Q4 		$33.1K Sell
478
-66
-12% -$4.59K 0.01% 325
2016
Q3 		$39.6K Buy
544
+27
+5% +$2.07K 0.01% 320
2016
Q2 		$39.6K Buy
517
+46
+10% +$3.3K 0.01% 291
2016
Q1 		$33.8K Buy
+471
New +$32.5K ﹤0.01% 351

Other funds holding K

WKKFT
W.K. Kellogg Foundation Trust Battle Creek, Michigan $3.7B AUM 1.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

Exane Derivatives's K Position: Q2 2022 in Review

Exane Derivatives reduced its Kellanova (K) stake by 12% in Q2 2022, selling an estimated $140K and leaving 15,356 shares worth $1.03M. The position accounts for 0.59% of the portfolio, ranked #40.

Exane Derivatives first reported a position in K in Q1 2016 and has held it in 26 quarters since. The position peaked at $1.06M in Q1 2022. 875 funds tracked by Wall St. Rank hold K as of Q2 2022.

  • Exane Derivatives held 15,356 shares of Kellanova worth $1.03M as of Q2 2022.
  • Exane Derivatives sold 2,160 Kellanova shares in Q2 2022, an estimated $140K.
  • Kellanova made up 0.59% of Exane Derivatives's portfolio in Q2 2022, its #40 holding.
  • Exane Derivatives first reported a position in Kellanova in Q1 2016 and has held it in 26 quarters since.
  • Exane Derivatives's Kellanova position peaked at $1.06M in Q1 2022.
  • 875 funds tracked by Wall St. Rank held Kellanova as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.